Biotech Companies

967 companies | Drug discovery and development companies

#	COMPANY	THERAPEUTIC AREAS	STAGE
1.	180 Collagen (NZ) Limited Te Awamutu, New Zealand		Commercial	VIEW
2.	1ST Biotherapeutics, Inc. Yongin, South Korea	Rare Diseases	Phase 1	VIEW
3.	3SBio Inc. Shenyang, China	Oncology Hematology Immunology	Phase 3	VIEW
4.	4 Animals AlsterScience GmbH Hamburg, Germany	Immunology Oncology Infectious Disease	Preclinical	VIEW
5.	4D Pharma plc Leeds, United Kingdom	Oncology Immunology Gastroenterology	Preclinical to Phase II (at time of administration)	VIEW
6.	AC Immune SA Lausanne, Switzerland		Phase 2	VIEW
7.	ACI Limited Dhaka, Bangladesh		Commercial	VIEW
8.	ADARx Pharmaceuticals San Diego, USA	Neuroscience Immunology Oncology	Phase 3	VIEW
9.	ADMA Biologics, Inc. Ramsey, New Jersey, United States		Commercial + Preclinical	VIEW
10.	AGS Therapeutics Paris, France	Ophthalmology Immunology Infectious Disease+2	Preclinical	VIEW
11.	AMR Action Fund Boston, United States	Infectious Disease	Phase 2/3 focus	VIEW
12.	ANSTO (Australian Nuclear Science and Technology Organisation) Sydney, Australia	Oncology Cardiovascular Neuroscience	Commercial	VIEW
13.	ARCS Australia North Sydney, Australia		-	VIEW
14.	ASKA Pharmaceutical Co., Ltd. Tokyo, Japan	Gastroenterology	Commercial	VIEW
15.	Aardvark Therapeutics San Diego, USA	Rare Diseases Metabolic	Phase 3	VIEW
16.	AbCellera Vancouver, Canada	Metabolic Immunology Oncology	Phase 2	VIEW
17.	Abbisko Therapeutics Shanghai, China	Oncology	Phase 3	VIEW
18.	Abcuro, Inc. Newton, Massachusetts, USA	Immunology Oncology Rare Diseases	Phase 2/3	VIEW
19.	Abdera Therapeutics South San Francisco, USA / Vancouver, Canada	Oncology	Phase 1	VIEW
20.	Abeona Therapeutics Inc. Cleveland, Ohio, USA	Rare Diseases Ophthalmology Dermatology	Commercial	VIEW
21.	Abiogen Pharma S.p.A. Pisa, Italy	Respiratory Metabolic Dermatology+1	Commercial	VIEW
22.	Abivax Paris, France	Immunology Gastroenterology	Phase 3	VIEW
23.	Acadia Pharmaceuticals Inc. San Diego, USA	Neuroscience Rare Diseases	Commercial	VIEW
24.	Acelot South San Francisco, California, USA	Metabolic Oncology	Preclinical	VIEW
25.	Acrux Melbourne, Australia	Dermatology Metabolic	Commercial	VIEW
26.	Actigen Company Limited Samut Sakhon, Thailand		Discovery	VIEW
27.	Actinogen Medical Sydney, Australia		Phase 2/3	VIEW
28.	Adium (Adium Paraguay / Fapasa) Asunción, Paraguay	Cardiovascular Metabolic Neuroscience+2	Commercial	VIEW
29.	AdvantiGen Biosciences Madison, WI, United States	Oncology Immunology	Discovery	VIEW
30.	Advanz Pharma London, United Kingdom	Gastroenterology Metabolic Oncology+2	Commercial\|Phase 2\|Phase 3	VIEW
31.	Aegros Macquarie Park, Australia	Infectious Disease Immunology	Clinical	VIEW
32.	Aerogen Pharma San Mateo, USA / Galway, Ireland	Respiratory	Phase 3	VIEW
33.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Oncology Immunology Infectious Disease	Clinical	VIEW
34.	Agios Pharmaceuticals Cambridge, USA	Rare Diseases Hematology Metabolic	Commercial	VIEW
35.	Agomab Therapeutics Antwerp, Belgium	Gastroenterology Rare Diseases	Phase 2	VIEW
36.	AiCuris Anti-infective Cures AG Wuppertal, Germany	Infectious Disease	Phase 3	VIEW
37.	Aitia Somerville, Massachusetts, USA	Oncology Immunology	Discovery	VIEW
38.	Ajou University Suwon, South Korea	Oncology Immunology Neuroscience+2	Phase 3	VIEW
39.	Akebia Therapeutics Cambridge, USA	Rare Diseases	Commercial	VIEW
40.	Akribes Biomedical Vienna, Austria	Dermatology	Preclinical	VIEW
41.	Al-Razi Pharma Industries Dammam, Saudi Arabia		Commercial	VIEW
42.	Alchemab Therapeutics Cambridge, United Kingdom	Oncology Immunology	Phase 1	VIEW
43.	Alembic Pharmaceuticals Limited Vadodara, India	Cardiovascular Dermatology Oncology+3	Commercial	VIEW
44.	Alkermes plc Dublin, Ireland	Neuroscience	Commercial	VIEW
45.	Alkeus Pharmaceuticals Cambridge, USA	Ophthalmology Rare Diseases	Phase 3	VIEW
46.	Allergy Therapeutics Worthing, United Kingdom		Phase 3 and Phase 1/2	VIEW
47.	Allygen Biosciences Shanghai, China	Oncology Immunology	Preclinical	VIEW
48.	Alnylam Pharmaceuticals Cambridge, USA	Infectious Disease	Commercial	VIEW
49.	AltruBio, Inc. San Francisco, USA	Immunology	Phase 2	VIEW
50.	Alumis Inc. South San Francisco, USA	Immunology Dermatology Neuroscience+1	Phase 3	VIEW
51.	Amarin Corporation plc Dublin, Ireland	Cardiovascular	Commercial	VIEW
52.	Ampersand Biomedicines Boston, MA, USA	Metabolic	Preclinical	VIEW
53.	Amylyx Pharmaceuticals Cambridge, USA	Rare Diseases	Phase 3	VIEW
54.	Anavex Life Sciences Corp. New York, United States	Oncology	Phase 2\|Phase 3	VIEW
55.	Angelini Pharma Rome, Italy	Neuroscience Infectious Disease	Phase 3	VIEW
56.	Anocca AB Södertälje, Sweden	Oncology Immunology Infectious Disease	Phase 1	VIEW
57.	Antaria Limited Perth, Australia		-	VIEW
58.	Anyea Therapeutics Co., Ltd. Shanghai, China	Neuroscience	Discovery	VIEW
59.	Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA	Ophthalmology Rare Diseases Immunology	Commercial	VIEW
60.	ApicHope Pharmaceutical Group Co., Ltd. Guangzhou, China	Metabolic Infectious Disease	Phase 3	VIEW
61.	Apogee Therapeutics, Inc. Waltham, USA	Dermatology Respiratory	Phase 2	VIEW
62.	Apotex Inc. Toronto, Canada	Cardiovascular Oncology Neuroscience+1	Commercial	VIEW
63.	Appili Therapeutics Inc. Halifax, Canada	Infectious Disease	Commercial	VIEW
64.	Aprogen Seongnam-si, South Korea	Oncology Immunology	Commercial	VIEW
65.	Apsen Farmacêutica São Paulo, Brazil	Neuroscience Gastroenterology	Phase 3	VIEW
66.	Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA	Oncology Infectious Disease Cardiovascular+2	Phase 2	VIEW
67.	Araceli Biosciences Tigard, Oregon, United States		Seed	VIEW
68.	Aramis Biotechnologies Quebec City, Canada	Infectious Disease	Phase 1/2	VIEW
69.	Arcera Life Sciences Abu Dhabi, United Arab Emirates	Neuroscience Cardiovascular Gastroenterology+1	Commercial	VIEW
70.	Arcus Biosciences Hayward, United States	Oncology Immunology	Phase 3	VIEW
71.	Arcutis Biotherapeutics Westlake Village, California, United States	Dermatology	Commercial & Phase 1/2	VIEW
72.	Ardelyx Waltham, Massachusetts, USA	Gastroenterology	Commercial	VIEW
73.	Argo Biopharma Shanghai, China	Cardiovascular Metabolic Hematology+2	Phase 2	VIEW
74.	Aristo Pharmaceuticals Private Limited Mumbai, India	Gastroenterology Respiratory	Commercial	VIEW
75.	Aristopharma Ltd. Dhaka, Bangladesh	Oncology Cardiovascular	Commercial	VIEW
76.	Ark Biosciences Shanghai, China	Respiratory Infectious Disease Neuroscience	Commercial	VIEW
77.	Arrivo BioVentures Morrisville, USA	Neuroscience Gastroenterology	Phase 2	VIEW
78.	Arrowhead Pharmaceuticals Pasadena, California, United States	Metabolic	Commercial \| Phase 3 \| Phase 2 \| Phase 1	VIEW
79.	Artica Therapeutics Leiden, Netherlands	Immunology	Preclinical	VIEW
80.	Artificial Axon Labs Cambridge, Massachusetts, USA	Neuroscience	Discovery	VIEW
81.	Arvinas, Inc. New Haven, Connecticut, United States	Oncology Neuroscience	Phase 1-3	VIEW
82.	AryoGen Pharmed Karaj, Iran	Oncology Immunology Hematology	Commercial	VIEW
83.	Ascentage Pharma Suzhou, China	Oncology	Commercial	VIEW
84.	Asclepii Cleveland, USA		Commercial	VIEW
85.	Asha Cellulose (I) Pvt. Ltd. Mumbai, India		-	VIEW
86.	Asia Euro Pharmaceutical Hanoi, Vietnam	Cardiovascular Respiratory Dermatology	Commercial	VIEW
87.	Asimetra Biotech Solutions Girona, Spain		-	VIEW
88.	AskGene Camarillo, California, United States	Oncology Immunology Ophthalmology	Phase 3	VIEW
89.	Asklepion Pharmaceuticals, LLC Baltimore, Maryland, USA		Phase 3	VIEW
90.	Asklepios BioPharmaceutical Research Triangle Park, North Carolina, USA	Metabolic	Phase 1\|Phase 2\|Preclinical	VIEW
91.	Aspen Global Incorporated Grand Bay, Mauritius	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
92.	Assertio Holdings, Inc. Lake Forest, USA	Neuroscience Immunology Oncology	Commercial	VIEW
93.	Assistance Publique - Hôpitaux de Marseille (AP-HM) Marseille, France	Rare Diseases Oncology	Clinical	VIEW
94.	AtaiBeckley (formerly ATAI Life Sciences) Berlin, Germany (original); U.S. redomiciliation completed December 30, 2025		Phase 2	VIEW
95.	Atara Biotherapeutics, Inc. Thousand Oaks, California, USA	Oncology Immunology	Clinical	VIEW
96.	Atea Pharmaceuticals Boston, Massachusetts, United States		Phase 3 (HCV), Phase 1 planned (HEV)	VIEW
97.	Aucta Pharmaceuticals Basking Ridge, New Jersey, USA	Dermatology Ophthalmology Respiratory	Commercial \| Phase 2 \| Preclinical	VIEW
98.	Aurion Biotech Seattle, USA	Ophthalmology	Phase 3	VIEW
99.	Autobahn Therapeutics San Diego, USA	Neuroscience	Phase 2	VIEW
100.	Autolus Therapeutics London, United Kingdom	Oncology Immunology Rare Diseases	Commercial + Phase 1/2	VIEW
101.	Avalon Pharma (Middle East Pharmaceutical Industries Co.) Riyadh, Saudi Arabia	Dermatology Respiratory Cardiovascular+3	Commercial	VIEW
102.	Avenzo Therapeutics San Diego, USA	Oncology	Phase 2	VIEW
103.	Axalbion Lausanne, Switzerland	Respiratory Ophthalmology Neuroscience	Phase 2	VIEW
104.	Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu Cagliari, Italy	Oncology Hematology Metabolic	Commercial	VIEW
105.	AziraMed Strategy Waterford, Ireland		-	VIEW
106.	Azurity Pharmaceuticals Woburn, USA	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
107.	B.Grimm Pharma Bangkok, Thailand	Cardiovascular Gastroenterology Infectious Disease+1	Commercial	VIEW
108.	BGI Group Shenzhen, China	Oncology Rare Diseases Infectious Disease	Commercial	VIEW
109.	BIAL São Mamede do Coronado, Trofa, Porto, Portugal	Cardiovascular Rare Diseases	Phase 2 (lead candidate)	VIEW
110.	BIKEN Foundation Suita, Japan	Infectious Disease	Commercial	VIEW
111.	BIOCAD Saint Petersburg, Russia	Oncology Immunology Infectious Disease	Commercial	VIEW
112.	BIOVIIIx Naples, Italy	Rare Diseases Hematology Oncology	Discovery	VIEW
113.	BRIM Biotechnology, Inc. Taipei, Taiwan	Ophthalmology Rare Diseases	Phase 3	VIEW
114.	Bain Capital Boston, USA	Oncology Rare Diseases Neuroscience	Commercial	VIEW
115.	Basilea Pharmaceutica Allschwil, Switzerland	Infectious Disease	Phase 3	VIEW
116.	Bavarian Nordic A/S Hellerup, Denmark	Infectious Disease Oncology Immunology	Commercial	VIEW
117.	BeBioSol India		-	VIEW
118.	BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025)	Oncology	Phase 1-3 and Commercial	VIEW
119.	Beacon Pharmaceuticals PLC Dhaka, Bangladesh	Oncology Cardiovascular Metabolic+2	Commercial	VIEW
120.	Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China	Cardiovascular Oncology Infectious Disease	Phase 2	VIEW
121.	Belenos Biosciences New York, NY, USA	Immunology Respiratory Dermatology	Phase 1/2	VIEW
122.	Belief BioMed Shanghai, China	Rare Diseases Hematology Neuroscience+1	Commercial	VIEW
123.	Belupo d.d. Koprivnica, Croatia	Cardiovascular Dermatology Infectious Disease	Commercial	VIEW
124.	BenevolentAI London, United Kingdom	Oncology Immunology Neuroscience+3	Phase 1\|Phase 2\|Preclinical	VIEW
125.	Benitec Biopharma Inc. Hayward, California, USA	Infectious Disease Oncology	Phase 1b/2a (BB-301), Preclinical (other programs)	VIEW
126.	Beren Therapeutics P.B.C. Thousand Oaks, USA	Rare Diseases	Phase 3	VIEW
127.	Berg Health Framingham, Massachusetts, USA	Oncology Neuroscience Rare Diseases	Phase 1/2	VIEW
128.	Besins Healthcare Monaco, Monaco	Metabolic	Commercial	VIEW
129.	Beta Drugs Limited Panchkula, India	Oncology Dermatology	Commercial	VIEW
130.	Bharat Biotech Hyderabad, India	Infectious Disease Oncology	Commercial	VIEW
131.	Bharat Serums and Vaccines Limited (BSV Group) Navi Mumbai, India		Commercial	VIEW
132.	Bicycle Therapeutics plc Cambridge, United Kingdom	Oncology	Phase 2	VIEW
133.	Bio Pharma Eco SL Spain		Discovery	VIEW
134.	Bio Usawa Inc. San Mateo, USA / Kigali, Rwanda	Oncology Infectious Disease Ophthalmology	Preclinical	VIEW
135.	Bio-Gene Technology Limited Shatin, Hong Kong		-	VIEW
136.	BioCardia, Inc. Sunnyvale, California, USA	Cardiovascular Respiratory	Phase 3	VIEW
137.	BioData Solutions Lawrence, Kansas, USA	Oncology Rare Diseases	-	VIEW
138.	BioInvent International AB Lund, Sweden	Oncology	Phase 2	VIEW
139.	BioLineRx Ltd. Modiin, Israel	Oncology Rare Diseases	Commercial	VIEW
140.	BioMarin Pharmaceutical Inc. San Rafael, USA	Hematology Metabolic Cardiovascular	Commercial	VIEW
141.	BioMed Valley Discoveries Kansas City, Missouri, USA	Oncology Immunology Rare Diseases+1	Clinical (Phase 1-2)	VIEW
142.	BioNTech Mainz, Germany	Oncology Immunology Infectious Disease	Phase 1-3	VIEW
143.	BioNTech SE Mainz, Germany	Oncology Infectious Disease Rare Diseases	Commercial	VIEW
144.	BioPartnersX Shanghai, China		Discovery	VIEW
145.	BioPharma Network Milan, Italy		-	VIEW
146.	Biocase Brasil Itajaí, Brazil		Preclinical	VIEW
147.	Biocodex Mexico Mexico City, Mexico	Gastroenterology Neuroscience Rare Diseases	Commercial	VIEW
148.	Biohaven Ltd. New Haven, USA	Neuroscience Immunology Oncology+1	Phase 3	VIEW
149.	Biological E. Limited Hyderabad, India	Infectious Disease Gastroenterology	Commercial	VIEW
150.	BiomeBank Adelaide, Australia	Infectious Disease Gastroenterology Metabolic	Clinical	VIEW
151.	Biomea Fusion San Carlos, USA	Metabolic Oncology	Phase 2	VIEW
152.	Biomed Industries, Inc. San Jose, USA	Metabolic	Phase 2/3	VIEW
153.	Biomedica Munich, Germany	Rare Diseases Oncology Hematology+2	Commercial	VIEW
154.	Bionexus (주식회사 바이오넥서스) Suwon, South Korea		Discovery	VIEW
155.	Bioreaction.tech (Bioreaction.tech Kft.) Debrecen, Hungary		Seed	VIEW
156.	BioscienceLA Culver City, USA		-	VIEW
157.	Biotest AG Dreieich (Frankfurt), Germany	Hematology	Phase 3/Commercial	VIEW
158.	Biotest AG Dreieich, Germany	Hematology	Phase 2\|Phase 3\|Commercial	VIEW
159.	Biovet AD Peshtera, Bulgaria		Commercial	VIEW
160.	Blau Farmacêutica S.A. Cotia, Brazil	Immunology Hematology Oncology+1	Commercial	VIEW
161.	BlossomHill Therapeutics San Diego, USA	Oncology Immunology	Phase 1	VIEW
162.	BlueRock Therapeutics Cambridge, USA	Neuroscience Cardiovascular Ophthalmology+1	Phase 3	VIEW
163.	Blueprint Medicines Cambridge, USA	Oncology Hematology Immunology+1	Commercial	VIEW
164.	Boostimmune Seoul, South Korea	Oncology Immunology	Preclinical	VIEW
165.	Bota Biosciences Hangzhou, China (International HQ in Lafayette, CA, USA)		Commercial	VIEW
166.	BrainXell, Inc. Madison, WI, USA	Neuroscience Rare Diseases	Preclinical	VIEW
167.	BridgeBio Oncology Therapeutics, Inc. South San Francisco, USA	Oncology	Phase 1	VIEW
168.	Bright Peak Therapeutics Allschwil, Switzerland	Oncology	Phase 1/2a	VIEW
169.	Brise Pharmaceuticals Shanghai, China		Phase 2	VIEW
170.	Bukwang Pharmaceutical Co., Ltd. Seoul, South Korea	Neuroscience Oncology	Phase 2	VIEW
171.	BunyaVax Lelystad, Netherlands	Infectious Disease Oncology	Phase 1	VIEW
172.	Burke Therapeutics, LLC Hot Springs, Arkansas, USA	Dermatology	Discovery	VIEW
173.	C-Ray Therapeutics Chengdu, China	Oncology	Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
174.	CAMP4 Therapeutics Cambridge, USA	Rare Diseases	Phase 1	VIEW
175.	CDR-Life Schlieren, Zurich, Switzerland	Oncology Immunology Ophthalmology	Phase 1	VIEW
176.	CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan	Oncology Neuroscience Infectious Disease	Preclinical	VIEW
177.	CEPI Oslo, Norway	Infectious Disease	Commercial	VIEW
178.	CF PharmTech, Inc. Suzhou, China	Respiratory	Commercial	VIEW
179.	CG Oncology, Inc. Irvine, USA	Oncology	Phase 3	VIEW
180.	CHA University Seongnam, South Korea		Discovery	VIEW
181.	CHA University Seongnam-si, South Korea		Discovery	VIEW
182.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Oncology Immunology Neuroscience+2	Phase 3	VIEW
183.	CS Pharmaceuticals Limited London, United Kingdom	Ophthalmology Rare Diseases	Phase 2	VIEW
184.	CSM Consulting, LLC United States	Cell Therapy Gene Therapy	-	VIEW
185.	CURE5 Foundation New York, USA	Rare Diseases Neuroscience	Discovery	VIEW
186.	Cabaletta Bio, Inc. Philadelphia, USA	Immunology Neuroscience Dermatology	Phase 1/2	VIEW
187.	Cal Crop USA USA		-	VIEW
188.	Caldera Therapeutics Cambridge, USA	Immunology Gastroenterology	Phase 1	VIEW
189.	Calico Life Sciences South San Francisco, United States	Oncology Neuroscience Immunology	Phase 2	VIEW
190.	Calidi Biotherapeutics San Diego, USA	Oncology	Phase 2	VIEW
191.	Calliditas Therapeutics Stockholm, Sweden	Rare Diseases	Commercial	VIEW
192.	Calluna Pharma Oslo, Norway	Immunology	Phase 2	VIEW
193.	Camurus AB Lund, Sweden	Neuroscience Rare Diseases Metabolic+1	Commercial	VIEW
194.	CanariaBio Inc. Seoul, South Korea	Oncology	Phase 3	VIEW
195.	Cancer Research UK London, United Kingdom	Oncology	Phase 2	VIEW
196.	Cantargia AB Lund, Sweden	Oncology Immunology	Phase 1 - Phase 2	VIEW
197.	Captor Therapeutics Wroclaw, Poland	Oncology Immunology	Preclinical	VIEW
198.	Capulus Therapeutics LLC San Francisco, United States	Oncology	Preclinical	VIEW
199.	Carbyne Equity Partners Hamburg, Germany		-	VIEW
200.	Cardurion Pharmaceuticals Burlington, United States	Cardiovascular	Phase 2	VIEW
201.	Caritas Healthcare Private Limited Ahmedabad, India	Oncology	Commercial	VIEW
202.	Carol Davila University of Medicine and Pharmacy Bucharest, Romania	Oncology Cardiovascular Rare Diseases	Discovery	VIEW
203.	Carrick Therapeutics Dublin, Ireland	Oncology	Phase 2	VIEW
204.	Carroll Bio-Consulting Boston, USA	Oncology Rare Diseases	Commercial	VIEW
205.	Cell-Tx Seoul, South Korea	Neuroscience Oncology Ophthalmology	Preclinical	VIEW
206.	Cellectar Biosciences, Inc. Florham Park, USA	Oncology Hematology	Phase 2	VIEW
207.	Cellectis Paris, France	Oncology Immunology Rare Diseases	Phase 2	VIEW
208.	Celon Pharma Łomianki, Poland	Neuroscience Oncology Immunology+1	Phase 3	VIEW
209.	Celularity Inc Florham Park, New Jersey, USA	Oncology	Phase 1/2 and Phase 2	VIEW
210.	Centaur Laboratories Private Limited Mumbai, India		-	VIEW
211.	Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong	Neuroscience Rare Diseases	Preclinical	VIEW
212.	Center of Molecular Immunology (CIM) Havana, Cuba	Oncology Immunology	Commercial	VIEW
213.	Centessa Pharmaceuticals Altrincham, United Kingdom	Neuroscience	Phase 2	VIEW
214.	Centrexion Therapeutics Boston, Massachusetts, United States	Immunology	Phase 1-3	VIEW
215.	Cerevel Therapeutics Cambridge, Massachusetts, USA		Phase 1-3	VIEW
216.	Chan Zuckerberg Biohub Network San Francisco, USA	Infectious Disease Rare Diseases Immunology	Discovery	VIEW
217.	Changchun GeneScience Pharmaceutical Co., Ltd. Changchun, China	Metabolic Oncology Immunology+1	Clinical	VIEW
218.	Chengdu Kanghong Pharmaceutical Group Chengdu, China	Ophthalmology Neuroscience Oncology	Commercial	VIEW
219.	Chiba University Chiba, Japan	Oncology Immunology Rare Diseases+3	Phase 2	VIEW
220.	China Isotope & Radiation Corporation (CIRC) Beijing, China	Oncology Cardiovascular	Commercial	VIEW
221.	China Medical System Holdings Ltd. Shenzhen, China	Dermatology Gastroenterology Ophthalmology+1	Commercial	VIEW
222.	China Medical University Hospital (CMUH) Taichung, Taiwan	Oncology Neuroscience Cardiovascular+2	Phase 2	VIEW
223.	Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China	Gastroenterology Hematology Oncology	Phase 3	VIEW
224.	Choose Life Biotech SA Bellinzona, Switzerland	Immunology Infectious Disease Oncology	Preclinical	VIEW
225.	Chosun University Hospital Gwangju, South Korea	Oncology Metabolic Gastroenterology	Discovery	VIEW
226.	ChuanXin Biomedicine Suzhou, China	Infectious Disease Oncology	Phase 1	VIEW
227.	Chung-Ang University Seoul, South Korea	Oncology Cardiovascular Immunology+2	Phase 3	VIEW
228.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Oncology Immunology Rare Diseases+4	Commercial	VIEW
229.	Circio Holding ASA Lysaker, Norway	Oncology Immunology Gene Therapy	Phase 1/2	VIEW
230.	City of Hope Duarte, California, USA	Oncology Hematology Rare Diseases	Commercial	VIEW
231.	Clasp Therapeutics Rockville, Maryland, USA	Oncology	Phase 1	VIEW
232.	Cleveland Clinic Foundation Cleveland, Ohio, USA	Oncology Cardiovascular Neuroscience+2	Discovery	VIEW
233.	Clever Culture Systems Adelaide, Australia		Commercial	VIEW
234.	Clinny Bio		-	VIEW
235.	Clinuvel Pharmaceuticals Melbourne, Australia	Rare Diseases Dermatology Neuroscience	Commercial	VIEW
236.	Coave Therapeutics Paris, France	Ophthalmology Neuroscience Rare Diseases	Preclinical	VIEW
237.	Cobel Darou Tehran, Iran	Cardiovascular Oncology Metabolic+3	Commercial	VIEW
238.	Cochener Garvey Capital Partners Wichita, USA		-	VIEW
239.	Codexis, Inc. Redwood City, California, USA	Rare Diseases Metabolic	Commercial	VIEW
240.	Coherus BioSciences, Inc. Redwood City, USA	Oncology	Commercial	VIEW
241.	College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences (SRIPMS) Coimbatore, India		-	VIEW
242.	Comanche Biopharma Corp. Concord, USA		Phase 1	VIEW
243.	Complement Therapeutics United Kingdom (University of Manchester spinout, with facilities in UK and Germany)	Ophthalmology	Phase I/II	VIEW
244.	Constructor Group Schaffhausen, Switzerland	Oncology Infectious Disease Neuroscience	Preclinical	VIEW
245.	Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, USA	Oncology Metabolic	Phase 3	VIEW
246.	Corcept Therapeutics Redwood City, USA	Metabolic Oncology Neuroscience	Commercial	VIEW
247.	Corline Biomedical AB Uppsala, Sweden	Metabolic Cardiovascular Neuroscience	Phase 2	VIEW
248.	Corona Remedies Limited Ahmedabad, India	Cardiovascular Gastroenterology Respiratory	Commercial	VIEW
249.	Cosmo Pharmaceuticals N.V. Dublin, Ireland	Gastroenterology Dermatology Infectious Disease	Commercial	VIEW
250.	Coya Therapeutics, Inc. Houston, USA	Immunology	Phase 2	VIEW
251.	Createrna Science and Technology Wuhan, China	Cardiovascular Respiratory Immunology	Phase 2	VIEW
252.	Crescent Biopharma, Inc. Waltham, USA	Oncology	Phase 1/2	VIEW
253.	Crescent Pharma Basingstoke, United Kingdom	Oncology Cardiovascular Infectious Disease	Commercial	VIEW
254.	Crixmor LLC Malvern, Pennsylvania, USA	Immunology Gastroenterology Oncology	Discovery	VIEW
255.	CryoLife Scientific LLP Thane, India		Discovery	VIEW
256.	Cugene Inc. Waltham, USA	Oncology Immunology	Phase 1	VIEW
257.	Cullinan Therapeutics Cambridge, USA	Oncology Immunology	Phase 3	VIEW
258.	CuraTeQ Biologics Hyderabad, India	Oncology Immunology Metabolic	Commercial	VIEW
259.	CuraVac Rixensart, Belgium	Immunology	Phase 1B (completed) \| Phase 2 (in preparation)	VIEW
260.	Curadev Pharma Pvt Ltd Noida, India	Oncology Immunology Metabolic	Phase 1	VIEW
261.	Curaleaf Holdings, Inc. Wakefield, Massachusetts, USA		Commercial	VIEW
262.	Curasight Copenhagen, Denmark	Oncology	Phase 1-2 Clinical	VIEW
263.	Curatis Liestal, Switzerland	Oncology Neuroscience Respiratory+1	Phase 3	VIEW
264.	Curative Biotechnology Inc Boca Raton, Florida, USA	Infectious Disease	Pre-Clinical\|IND-Enabling Studies	VIEW
265.	CureVac Tübingen, Germany	Oncology Infectious Disease Rare Diseases	Phase 2	VIEW
266.	Curis, Inc. Lexington, USA	Oncology	Phase 1/2	VIEW
267.	Curocell Inc. Daejeon, South Korea	Oncology Hematology	Commercial	VIEW
268.	CytoAgents Pittsburgh, USA	Oncology Immunology Infectious Disease+1	Phase 2	VIEW
269.	CytoDyn Inc Vancouver, Washington	Oncology Immunology	Phase 2 clinical	VIEW
270.	CytoImmune Therapeutics Duarte, USA	Oncology Hematology Immunology	Phase 1	VIEW
271.	CytoSen Therapeutics Orlando (Winter Springs), Florida, USA	Oncology Cell Therapy Immunology	Phase 2	VIEW
272.	CytoTools AG Heidelberg, Germany	Dermatology Cardiovascular Oncology	Phase 3	VIEW
273.	CytoVac Hørsholm, Denmark	Oncology	Phase 2	VIEW
274.	Cytochroma Edinburgh, United Kingdom	Cardiovascular Rare Diseases	Discovery	VIEW
275.	Cytocom, Inc. Fort Collins, Colorado, USA	Oncology Infectious Disease Hematology+1	Phase 2/Phase 3	VIEW
276.	Cytokinetics, Incorporated South San Francisco, USA	Cardiovascular	Commercial	VIEW
277.	Cytolab SPA Boumerdès, Algeria		Commercial	VIEW
278.	CytomX Therapeutics, Inc. South San Francisco, California, United States	Oncology	Phase 1 (clinical), Preclinical (discovery collaborations)	VIEW
279.	Cytomos Edinburgh, United Kingdom	Cell Therapy Gene Therapy Oncology	Commercial	VIEW
280.	Cytonics Corporation Jupiter, Florida, USA	Immunology	Phase 2	VIEW
281.	Cytonus Therapeutics Carlsbad, California, United States	Oncology Immunology Infectious Disease+1	Phase 1	VIEW
282.	Cytorex Biosciences Weston, Florida, USA	Oncology Metabolic Infectious Disease	Preclinical	VIEW
283.	Cytovation Bergen, Norway	Oncology Rare Diseases	Phase I/II - Phase II	VIEW
284.	Cytovia Therapeutics Aventura, Florida, USA	Oncology Immunology	Phase 1/2	VIEW
285.	Cyxone Malmö, Sweden	Immunology Neuroscience	Phase 2	VIEW
286.	D&D Pharmatech Seongnam-si, South Korea		Phase 2	VIEW
287.	DBV Technologies Châtillon, France	Immunology	Phase 3	VIEW
288.	Daeyeon Chemical Co., Ltd. Seongnam-si, South Korea		-	VIEW
289.	Dankook University Yongin and Cheonan, South Korea	Oncology Neuroscience Rare Diseases+1	Phase 2	VIEW
290.	Dartmouth College Hanover, USA	Oncology Immunology Neuroscience+2	Phase 3	VIEW
291.	Day One Biopharmaceuticals Brisbane, United States	Oncology Rare Diseases	Commercial	VIEW
292.	Debiopharm Lausanne, Switzerland	Oncology Rare Diseases	Phase 1, Phase 2, Phase 3	VIEW
293.	Deep Life Medical Ltd Edinburgh, United Kingdom		Phase 1	VIEW
294.	Dendreon Pharmaceuticals Seal Beach, USA	Oncology	Commercial	VIEW
295.	DesiCorp Inc. Louisville, USA		Preclinical	VIEW
296.	DevaCell, Inc. San Diego, USA	Oncology Infectious Disease Gene Therapy	Preclinical	VIEW
297.	Development Center for Biotechnology (DCB) Taipei, Taiwan	Oncology Immunology Infectious Disease	Preclinical	VIEW
298.	Dexa Medica Tangerang, Indonesia	Oncology	Commercial	VIEW
299.	Dexcel Pharma Or Akiva, Israel	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
300.	Diamond Pharma Damascus, Syria	Cardiovascular Respiratory	Commercial	VIEW
301.	DifGen Pharmaceuticals Miramar, USA	Ophthalmology Neuroscience	Commercial	VIEW
302.	Differential Bio Munich, Germany		Commercial	VIEW
303.	Dignify Therapeutics Research Triangle Park, NC, USA	Neuroscience Gastroenterology	Clinical	VIEW
304.	Disc Medicine, Inc. Watertown, Massachusetts, USA	Hematology Rare Diseases	Phase 3	VIEW
305.	Dizal Pharmaceutical Shanghai, China	Oncology Immunology	Commercial	VIEW
306.	Dolomite TX		-	VIEW
307.	Dolor Therapeutics, Inc. Chicago, USA	Immunology	Preclinical	VIEW
308.	Dompé Farmaceutici Milan, Italy	Ophthalmology Rare Diseases Metabolic+2	Commercial	VIEW
309.	Dr. Falk Pharma GmbH Freiburg, Germany	Gastroenterology Immunology	Phase 3	VIEW
310.	Dr. L. H. Hiranandani College of Pharmacy Ulhasnagar, India		Discovery	VIEW
311.	Drugs for Neglected Diseases initiative (DNDi) Geneva, Switzerland	Infectious Disease	Commercial	VIEW
312.	Duality Biologics Shanghai, China	Oncology Immunology	Phase 3	VIEW
313.	Duopharma Biotech Berhad Kuala Lumpur, Malaysia	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
314.	Dyne Therapeutics, Inc. Waltham, Massachusetts, USA		Phase 1/2, Phase 3	VIEW
315.	E-Flask Seongnam, South Korea	Neuroscience Oncology	Phase 1	VIEW
316.	EEE Pharma Maharashtra, India	Infectious Disease Immunology Cardiovascular+1	Commercial	VIEW
317.	EIPICO 10th of Ramadan City, Egypt	Oncology Ophthalmology Cardiovascular+1	Phase 3	VIEW
318.	ETH Zürich Zurich, Switzerland	Oncology Immunology Neuroscience+4	Discovery	VIEW
319.	EUBREAST Esslingen, Germany	Oncology	Phase 3	VIEW
320.	East West Pharma Salem, India	Cardiovascular Dermatology	Commercial	VIEW
321.	Edge Therapeutics, Inc. Princeton, New Jersey, USA	Oncology Infectious Disease	Phase 3	VIEW
322.	Edgewise Therapeutics Boulder, USA		Phase 2	VIEW
323.	EdiLabs OÜ Harku, Estonia	Neuroscience Immunology	Discovery	VIEW
324.	Efroze Chemical Industries (Pvt.) Ltd. Karachi, Pakistan	Cardiovascular Gastroenterology	Commercial	VIEW
325.	Eledon Pharmaceuticals Irvine, USA	Immunology	Phase 2	VIEW
326.	Elevar Therapeutics Fort Lee, USA	Oncology	Phase 3	VIEW
327.	Eleven Therapeutics Cambridge, United Kingdom	Infectious Disease	Discovery	VIEW
328.	Elixiron Immunotherapeutics Taipei, Taiwan	Oncology Immunology	Phase 2	VIEW
329.	Ellipses Pharma London, United Kingdom	Oncology	Phase 1/2	VIEW
330.	Emergent BioSolutions Gaithersburg, Maryland, USA	Infectious Disease	Commercial	VIEW
331.	Empresa de Laboratorios AICA La Lisa, Havana, Cuba	Infectious Disease Oncology	Commercial	VIEW
332.	Enanta Pharmaceuticals, Inc. Watertown, Massachusetts, USA	Immunology	Phase 1-2 clinical	VIEW
333.	Eneapharm Labège, France	Gastroenterology Rare Diseases	Clinical	VIEW
334.	Enlivex Therapeutics Ltd. Ness Ziona, Israel	Immunology Oncology Infectious Disease	Phase 2	VIEW
335.	Ensem Therapeutics Waltham, MA, USA	Oncology	Phase 1/2	VIEW
336.	Entact Bio Watertown, USA	Oncology Immunology Rare Diseases	Preclinical	VIEW
337.	Epione Medicine ApS Hvidovre, Denmark		-	VIEW
338.	Eris Therapeutics Limited Ahmedabad, India	Cardiovascular Gastroenterology Dermatology	Commercial	VIEW
339.	Estetra SRL Liège, Belgium	Oncology	Commercial	VIEW
340.	Ethypharm Saint-Cloud, France	Neuroscience	Commercial	VIEW
341.	Eugia US LLC East Windsor, New Jersey, USA	Oncology Respiratory Hematology+2	Commercial	VIEW
342.	EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany	Oncology Immunology Neuroscience+2	Commercial	VIEW
343.	Everest Medicines Shanghai, China	Immunology Oncology Cardiovascular+1	Commercial	VIEW
344.	Evopoint Biosciences Suzhou, China	Oncology Infectious Disease Immunology	Commercial (NDA Stage)	VIEW
345.	Evotec SE Hamburg, Germany	Oncology Neuroscience Infectious Disease+1	Commercial	VIEW
346.	Evox Therapeutics Oxford, United Kingdom	Rare Diseases Oncology	Preclinical	VIEW
347.	Exelixis Alameda, USA	Oncology	Commercial	VIEW
348.	Exeltis Florham Park, USA (Global HQ in Madrid, Spain)	Neuroscience Respiratory Dermatology+2	Commercial	VIEW
349.	Exlixis		-	VIEW
350.	EyePoint Pharmaceuticals Watertown, Massachusetts, USA	Ophthalmology	Phase 3	VIEW
351.	FDC Limited Mumbai, India	Gastroenterology Ophthalmology Cardiovascular+2	Commercial	VIEW
352.	FELIQS Corporation Fukuoka, Japan	Ophthalmology Rare Diseases	Phase 1	VIEW
353.	FNCT Biotech Seongnam-si, South Korea	Oncology Immunology	Preclinical	VIEW
354.	FORE Biotherapeutics Philadelphia, USA	Oncology	Phase 2	VIEW
355.	Faes Farma Leioa, Spain	Gastroenterology Ophthalmology Dermatology	Phase 3	VIEW
356.	Fapon Dongguan, China	Oncology Immunology Infectious Disease	Preclinical	VIEW
357.	Farmacéutica Hispanoamericana S.A. de C.V. Ciudad de México, Mexico	Respiratory Cardiovascular Gastroenterology	Commercial	VIEW
358.	Farmak Kyiv, Ukraine	Metabolic Gastroenterology Cardiovascular+3	Commercial	VIEW
359.	Farmaprim Porumbeni, Moldova		Commercial	VIEW
360.	Fate Therapeutics, Inc. San Diego, USA	Oncology	Phase 1	VIEW
361.	Feldan Therapeutics Québec City, Canada	Oncology Dermatology	Preclinical	VIEW
362.	FenoMark Diagnostics AB Solna, Sweden	Oncology	Discovery	VIEW
363.	Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil	Infectious Disease Vaccines Rare Diseases+1	Commercial	VIEW
364.	Fishfa Biogenics Rajkot, India	Immunology Infectious Disease Oncology+1	Commercial	VIEW
365.	Flagship Pioneering Cambridge, USA	Oncology Immunology Cardiovascular+2	Discovery	VIEW
366.	Flare Therapeutics Cambridge, MA, USA	Oncology	Phase 1-1B	VIEW
367.	FluGen, Inc. Madison, USA	Infectious Disease	Phase 2	VIEW
368.	Focus Care Pharmaceuticals B.V. Zaandam, Netherlands	Respiratory Neuroscience Cardiovascular+1	Commercial	VIEW
369.	For Benefit Medicines Sydney, Australia	Oncology	Commercial	VIEW
370.	Forma Therapeutics Inc Watertown, USA	Hematology Oncology Rare Diseases	Phase 3	VIEW
371.	Formation Bio New York, USA	Immunology Dermatology Neuroscience	Phase 3	VIEW
372.	Formycon AG Planegg-Martinsried, Germany	Ophthalmology Immunology	Commercial	VIEW
373.	Frontier Medicines South San Francisco, USA	Oncology Immunology	Phase 1/2	VIEW
374.	Fundação Butantan São Paulo, Brazil	Infectious Disease	Phase 2	VIEW
375.	Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada	Oncology	Phase 1\|Phase 2\|Phase 3	VIEW
376.	Future Health Biobank Nottingham, United Kingdom		-	VIEW
377.	G. H. Raisoni University Saikheda, India	Oncology Metabolic Neuroscience+1	Discovery	VIEW
378.	GEN İlaç Ankara, Turkey	Oncology Neuroscience Metabolic+3	Phase 1\|Phase 2\|Commercial	VIEW
379.	GENFIT Loos, France	Metabolic	Phase 2	VIEW
380.	GNT Pharma Yongin, South Korea	Neuroscience Respiratory	Phase 3	VIEW
381.	Galapagos NV Mechelen, Belgium	Immunology Oncology	Phase 2	VIEW
382.	Galen Limited Craigavon, United Kingdom	Dermatology Gastroenterology Metabolic	Commercial	VIEW
383.	Galenicap BV Brussels, Belgium	Oncology Neuroscience Infectious Disease	Phase 2	VIEW
384.	Galpha Laboratories Limited Mumbai, India	Infectious Disease Gastroenterology Dermatology	Commercial	VIEW
385.	Gan & Lee Pharmaceuticals Beijing, China	Metabolic Oncology Cardiovascular	Commercial	VIEW
386.	GenAns Biotech Beijing, China	Neuroscience Ophthalmology Oncology	Preclinical	VIEW
387.	GenLumina Leiden, Netherlands	Oncology	Preclinical	VIEW
388.	Gene Oasis Singapore, Singapore	Oncology Neuroscience Immunology+1	Clinical	VIEW
389.	GeneBiology, Inc. Research Triangle Park, North Carolina, USA	Oncology Neuroscience Gastroenterology	Clinical	VIEW
390.	GeneScience Pharmaceuticals Co., Ltd. (GenSci) Changchun, China	Metabolic Immunology Respiratory+1	Commercial	VIEW
391.	Genentech South San Francisco, California, United States	Oncology Immunology Rare Diseases+3	Discovery through Commercial	VIEW
392.	Genfarma Joint Stock Company Hanoi, Vietnam	Oncology Immunology Neuroscience+1	Commercial	VIEW
393.	Genmab Copenhagen, Denmark	Oncology Hematology Immunology	Commercial	VIEW
394.	Gensciences Nantong, China	Hematology	Phase 3	VIEW
395.	George Mason University Fairfax, USA	Oncology Infectious Disease Metabolic+2	Phase 2	VIEW
396.	Georgia Southern University Statesboro, USA	Oncology Infectious Disease Neuroscience+1	Discovery	VIEW
397.	Gesynta Pharma AB Stockholm, Sweden		Phase 2	VIEW
398.	Ghosts Past		-	VIEW
399.	Google (Google DeepMind / Isomorphic Labs) London, United Kingdom	Oncology Immunology Cardiovascular	Preclinical	VIEW
400.	Granite Bio Basel, Switzerland	Immunology	Phase 1	VIEW
401.	Grit Biotechnology Shenzhen, China	Oncology Immunology	Phase 2	VIEW
402.	Grupo Leti Guarenas, Venezuela	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
403.	Grupo Medifarma, S.A. de C.V. Jiutepec, Mexico	Gastroenterology	Commercial	VIEW
404.	Guangzhou Cellprotek Pharmaceutical Guangzhou, China	Neuroscience Cardiovascular Immunology+1	Phase 3 (Planning)	VIEW
405.	Gustave Roussy Villejuif, France	Oncology	Discovery	VIEW
406.	HBM Partners Zug, Switzerland	Oncology Immunology Neuroscience+3	Commercial	VIEW
407.	HCW Biologics Inc. Miramar, Florida, USA	Oncology Immunology	Phase 2	VIEW
408.	HERMES Arzneimittel Holding Pullach im Isartal, Germany		Commercial	VIEW
409.	HERVolution Therapeutics Copenhagen, Denmark	Oncology	Preclinical	VIEW
410.	HGFH (Placeholder Entity) N/A		Discovery	VIEW
411.	HIPRA Amer, Spain		Commercial	VIEW
412.	HLB PEP Co., Ltd. Gwangju, South Korea	Oncology Rare Diseases Immunology	Preclinical	VIEW
413.	HUN-REN Veterinary Medical Research Institute (VMRI) Budapest, Hungary	Infectious Disease	Discovery	VIEW
414.	HUTCHMED Hong Kong	Oncology Immunology Dermatology	Discovery to Phase III	VIEW
415.	Halo Life Science Austin, Texas, United States	Immunology	Discovery	VIEW
416.	Halozyme Therapeutics San Diego, USA	Oncology Immunology Neuroscience+3	Commercial	VIEW
417.	Hamad Bin Khalifa University (HBKU) Doha, Qatar	Oncology Metabolic Infectious Disease+1	Preclinical	VIEW
418.	Hanan Medicare Sdn. Bhd. Rawang, Malaysia	Metabolic	Commercial	VIEW
419.	Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Metabolic Rare Diseases+1	Commercial	VIEW
420.	HansBiomed Seoul, South Korea	Dermatology	Commercial	VIEW
421.	Hansa Biopharma Lund, Sweden	Immunology Gene Therapy Oncology	Commercial	VIEW
422.	Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China	Oncology Neuroscience Metabolic+1	Phase 3	VIEW
423.	Hanyang University Seoul, South Korea	Oncology Neuroscience Infectious Disease+1	Phase 2	VIEW
424.	Harbour BioMed Shanghai, China	Oncology Immunology Ophthalmology	Phase 3	VIEW
425.	Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA	Neuroscience Rare Diseases	Commercial	VIEW
426.	Healios K.K. Tokyo, Japan	Neuroscience Oncology Ophthalmology	Phase 3	VIEW
427.	Healis Therapeutics Cambridge, USA	Neuroscience	Phase 2/3	VIEW
428.	Health Hope Pharma Hong Kong, Hong Kong	Oncology	Phase 3	VIEW
429.	Hedera Dx Epalinges, Switzerland	Oncology	Commercial	VIEW
430.	Heligenics Phoenix, Arizona, USA	Oncology Rare Diseases	Discovery	VIEW
431.	Hemerion Therapeutics Villeneuve d'Ascq, France	Oncology	Phase 1/2	VIEW
432.	HepaRegeniX GmbH Tübingen, Germany	Oncology Neuroscience	Phase 2	VIEW
433.	Heranova Lifesciences Burlington, MA, USA		Clinical	VIEW
434.	Hetero Drugs Limited Hyderabad, India	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
435.	Hevolution Foundation Riyadh, Saudi Arabia	Oncology Neuroscience Rare Diseases	Discovery	VIEW
436.	HighQ Technologies Waterloo, Canada		Discovery	VIEW
437.	Highnoon Laboratories Limited Lahore, Pakistan	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
438.	Himalaya Wellness Company Bengaluru, India		Commercial	VIEW
439.	Himont Group Lahore, Pakistan		Commercial	VIEW
440.	Holostem S.r.l. Modena, Italy	Ophthalmology Dermatology Rare Diseases	Commercial	VIEW
441.	Hone Bio Bristol, United Kingdom	Oncology Cardiovascular	Preclinical	VIEW
442.	Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China	Oncology Neuroscience Ophthalmology+1	Phase 2	VIEW
443.	Houston Methodist Houston, USA	Oncology Cardiovascular Neuroscience+1	Discovery	VIEW
444.	Howard University Washington, D.C., USA	Oncology Immunology Cardiovascular	Discovery	VIEW
445.	Huahui Health Ltd. Beijing, China	Oncology	Commercial	VIEW
446.	Huapont Life Sciences Co., Ltd. Chongqing, China	Dermatology Respiratory Oncology+1	Commercial	VIEW
447.	Hudson Pharmaceuticals Ltd. Dhaka, Bangladesh	Respiratory Ophthalmology Gastroenterology+2	Commercial	VIEW
448.	Humanitas Research Hospital (IRCCS) Rozzano (Milan), Italy	Oncology Immunology Cardiovascular+1	Discovery	VIEW
449.	Humanova Lab Corporation Coral Gables, USA (Registered); Lima, Peru (Operational)		Commercial	VIEW
450.	Humatrix Medical Suzhou, China	Cardiovascular	Preclinical/Early Clinical	VIEW
451.	Huons Co., Ltd. Seongnam, South Korea	Ophthalmology Metabolic	Commercial	VIEW
452.	Hyloris Pharmaceuticals SA Liège, Belgium	Cardiovascular Infectious Disease Oncology+1	Commercial	VIEW
453.	HyperMabs Inc. Montreal, Canada	Oncology Infectious Disease	Discovery	VIEW
454.	Hyphens Pharma Singapore, Singapore	Dermatology	Commercial	VIEW
455.	I.E. Medica, Inc. Mandaluyong, Philippines	Oncology	Commercial	VIEW
456.	IBSA Institut Biochimique SA Lugano, Switzerland	Metabolic Dermatology Respiratory	Commercial	VIEW
457.	IDEAYA Biosciences South San Francisco, USA	Oncology	Phase 3	VIEW
458.	IFPMA Geneva, Switzerland	Infectious Disease Vaccines	-	VIEW
459.	IMIDomics, Inc. San Rafael, USA	Immunology Dermatology	Discovery	VIEW
460.	IMTR Inc. Tokyo, Japan	Immunology Hematology Gastroenterology	Phase 1/2	VIEW
461.	IPS Biopharma AG Bern, Switzerland	Oncology Infectious Disease	Phase 2	VIEW
462.	ITESO, Universidad Jesuita de Guadalajara Tlaquepaque, Mexico		Discovery	VIEW
463.	Iasis Pharma Kamatero, Greece	Cardiovascular Dermatology Gastroenterology+3	Commercial	VIEW
464.	Ibn Al-Haytham Pharmaceutical Industries Aleppo, Syria	Cardiovascular	Commercial	VIEW
465.	Idorsia Allschwil, Switzerland	Neuroscience Cardiovascular Immunology+1	Commercial	VIEW
466.	Ignis Therapeutics Shanghai, China	Neuroscience	Phase 3	VIEW
467.	Imexpharm Corporation Cao Lãnh, Vietnam	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
468.	Immatics N.V. Tübingen, Germany	Oncology	Phase 2	VIEW
469.	Immedica Pharma AB Stockholm, Sweden		Commercial	VIEW
470.	Immorna Biotherapeutics Morrisville, USA	Oncology Infectious Disease Dermatology+1	Phase 2	VIEW
471.	Immune System Key Ltd. (ISK) Jerusalem, Israel	Oncology	Phase 2	VIEW
472.	Immuneel Therapeutics Bengaluru, India	Oncology Hematology Immunology	Commercial	VIEW
473.	Immunethep Cantanhede, Portugal	Infectious Disease Immunology	Preclinical	VIEW
474.	Immunis, Inc. Irvine, California, USA	Immunology	Phase 1/2	VIEW
475.	ImmunityBio, Inc. Culver City, California, USA	Oncology Infectious Disease	Commercial	VIEW
476.	Immunocore Abingdon, United Kingdom	Oncology Infectious Disease Immunology	Commercial	VIEW
477.	Immunome, Inc. Bothell, Washington, USA	Oncology	Phase 3	VIEW
478.	Immunomic Therapeutics, Inc. Rockville, Maryland, United States	Oncology Infectious Disease	Phase 1 - Phase 2	VIEW
479.	Immunophotonics Saint Louis, Missouri, USA	Oncology Immunology	Phase 2/3	VIEW
480.	Immunovant, Inc. Durham, North Carolina, USA	Immunology Neuroscience Metabolic+1	Phase 3	VIEW
481.	Impact Therapeutics, Inc. Shanghai, China	Oncology	Commercial	VIEW
482.	Incepta Vaccine Ltd. Dhaka, Bangladesh	Infectious Disease	Commercial	VIEW
483.	Incyte Wilmington, Delaware, USA	Oncology Hematology Dermatology+1	Commercial	VIEW
484.	Indian Immunologicals Limited Hyderabad, India	Infectious Disease Immunology	Commercial	VIEW
485.	Indoco Remedies Limited Mumbai, India	Respiratory Cardiovascular	Commercial	VIEW
486.	Industrial Technology Research Institute (ITRI) Hsinchu County, Taiwan		Discovery	VIEW
487.	Infinitopes Oxford, United Kingdom	Oncology	Phase 1/IIa	VIEW
488.	Ingentec Corporation Miaoli, Taiwan		-	VIEW
489.	Ingpharm (ООО ИНЖФАРМ) Moscow, Russia		-	VIEW
490.	Initial Therapeutics South San Francisco, USA	Oncology Rare Diseases	Discovery	VIEW
491.	Innovacell Tokyo, Japan	Gastroenterology	Phase 3	VIEW
492.	Innovative Cell Technologies, Inc. San Diego, United States		Commercial	VIEW
493.	Innovent Biologics, Inc. Suzhou, China	Oncology	Commercial	VIEW
494.	Inresa Arzneimittel GmbH Freiburg im Breisgau, Germany	Oncology Infectious Disease	Commercial	VIEW
495.	InsilicoX Co., Ltd. Seoul, South Korea		Discovery	VIEW
496.	Insmed Incorporated Bridgewater, New Jersey, USA	Immunology Rare Diseases	Commercial	VIEW
497.	Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain	Oncology Neuroscience Rare Diseases+2	Preclinical	VIEW
498.	Institute of Biophysics and Biomedical Engineering (BAS) Sofia, Bulgaria	Oncology Neuroscience Cardiovascular	Discovery	VIEW
499.	Institute of Immunology (Imunološki zavod) Zagreb, Croatia	Infectious Disease Immunology	Discovery	VIEW
500.	Instituto Politécnico Nacional (IPN) Mexico City, Mexico	Oncology Rare Diseases Infectious Disease	Discovery	VIEW